Selumetinib Clinical Trial for Cutaneous Neurofibromas - Tumor Measures Data

syn69027668

Data hosted and governed on Synapse.org and Knowledge Portals by Sage Bionetworks.
Created By Anh Nguyet Vu avu

title: Selumetinib Clinical Trial for Cutaneous Neurofibromas - Tumor Measures Data
funder: NIH-NCI
creator: Bruce Korf Ashley Cannon
license: https://creativecommons.org/licenses/by/4.0/
species: Homo sapiens
studyId: syn8012530
subject: Medicine Neurofibromatosis Clinical trials
citation: JAMA Dermatol. 2025;161(5):533-537. doi:10.1001/jamadermatol.2024.6574
dataType: clinical
keywords: selumetinib cutaneous neurofibromas dermal neurofibromas MEK inhibitor
accessType: Public Access
contributor: Andrea Gross Lauren Baldwin
diseaseFocus: Neurofibromatosis type 1
manifestation: Cutaneous Neurofibroma Quality of Life
countryOfOrigin: US
individualCount: 11
dataUseModifiers: General Research Use
measurementTechnique: in vivo tumor growth
includedInDataCatalog: https://www.synapse.org/DataCatalog:0

Your web browser must have JavaScript enabled in order for this application to display correctly.
If you are an automated web crawler from a search engine, follow this AJAX application crawl link

Selumetinib Clinical Trial for Cutaneous Neurofibromas - Tumor Measures Data

syn69027668

Drop files to upload

Selumetinib Clinical Trial for Cutaneous Neurofibromas - Tumor Measures Data page is loading…